Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Aseko dba Glytec is raising $12,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Edmond Furlong played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Aseko dba Glytec

Founded in 2006, Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Our FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized insulin treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment including those with and without a diagnosis of diabetes.

To learn more about Aseko dba Glytec, visit http://www.glytecsystems.com/

Contact:
Edmond Furlong, Chief Executive Officer
864-370-3297
efurlong@glytecsystems.com
https://www.linkedin.com/in/ed-furlong-6b8b092b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved